Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
about
MDM2 negatively regulates the human telomerase RNA gene promoterA mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal HaemoglobinuriaThe Telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particleSpecies-specific organization of CpG island promoters at mammalian homologous genes.Natural and pharmacological regulation of telomeraseThe scaRNA2 is produced by an independent transcription unit and its processing is directed by the encoding regionTelomerase and cancer: time to move from a promising target to a clinical reality.Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.Telomerase and telomeres: from basic biology to cancer treatment.Zoning of mucosal phenotype, dysplasia, and telomerase activity measured by telomerase repeat assay protocol in Barrett's esophagusSignaling through estrogen receptors modulates telomerase activity in human prostate cancer.MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity.Telomerase as a novel and potentially selective target for cancer chemotherapy.Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes.Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies.Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domainActivation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3.Peculiarities of Yeasts and Human Telomerase RNAs Processing.Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels.The RNA subunit of telomerase is encoded by Marek's disease virus.Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth.Structural features of mouse telomerase RNA are responsible for the lower activity of mouse telomerase versus human telomerase.The combination of TRAIL treatment and cancer cell selective expression of TRAIL-death receptor DR4 induces cell death in TRAIL-resistant cancer cells.The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.The association between telomerase activity and expression of its RNA component (hTR) in breast cancer patients: the importance of DNase treatment.Structural Features of the Telomerase RNA Gene in the Naked Mole Rat Heterocephalus glaber.The regulation of telomerase in oncogenesis.Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene.Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.Telomerase in cancer: clinical applications.
P2860
Q24793105-6B82B2A2-D71B-4E83-9F70-78EB171B6C78Q24799321-0BCA51DE-D44C-4957-85D8-0A833322A601Q28142206-F21C3A61-E2DB-454F-8E26-323942BB3710Q28343947-11114F03-C6D7-4255-ADCF-7598BBBAB6F1Q31038583-B6834579-A72B-4189-A91A-E3E2BDF8280FQ33608901-C225E56C-8E71-41BD-A127-6F832E6D9260Q34464335-C3BADF18-2978-4158-A242-0BB98E868F7CQ34506827-41A5C8B2-1025-49AB-82B5-2B18B034902DQ34538689-4C2F6F55-AE25-4BA9-833D-0B6B39463987Q34787887-F18BD61F-FAB5-4BC9-9B4E-598BF302BE7DQ34794033-15158D30-CF00-4D70-A8C4-7431042E61AAQ34910264-4D3D9F46-85C6-4CF6-8E35-F83669BDB911Q35597618-6D0966E6-77B6-4CEF-A4BC-F7367BEC9C86Q35746441-1F9D8AC3-E295-49D7-A032-3221DDE793A0Q36303872-AA5539EC-9B9F-4430-8E0D-1D70D35C4F70Q36814078-057ADF59-3D81-4275-8E68-141A34B00D0AQ38303623-31C7A25E-B286-4430-BEC4-787DF663F3C5Q39066545-6B229CF2-FD32-45A7-B16E-142528436B7AQ39551372-9C4D1D05-3505-4FE0-AC71-1FD42C93368DQ39748978-8F1726A8-7627-42EB-8969-F07909CF475DQ40228737-AC304AA5-DA4D-488C-A3F9-B64852F0AE4BQ40284536-4043F4F3-2DF6-40D3-ACBE-8D2AA6E8C51BQ40311281-302F94AC-F49E-4B9F-9F90-CF188D161E8DQ40394964-6DC7A206-9951-4A61-9B1B-0894A3EDD604Q41677077-32ED5DF7-75FE-47BA-81E3-B033F8D26226Q42003187-4A83BA1E-FE84-4A16-A722-E265C0D7D858Q42152999-2F8695BB-BCA9-41E5-9049-B9E58E66B919Q42437075-011C0C19-A545-42D7-828B-ED84425F08F1Q43831003-7C7AE062-1D36-47B1-81AE-B49091FBC114Q43831004-42FB5FD1-EFDF-4C47-BC65-3266147803E9Q46450385-0383C52A-9F60-45DC-82CD-21514EDE9902
P2860
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@ast
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@en
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@nl
type
label
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@ast
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@en
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@nl
prefLabel
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@ast
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@en
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@nl
P2093
P356
P1433
P1476
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences
@en
P2093
E K Parkinson
R McFarlane
P2888
P304
P356
10.1038/SJ.ONC.1201892
P407
P577
1998-03-12T00:00:00Z
P5875
P6179
1040928388